Jennifer N. Durham

机构：Bloomberg (United States), Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore · ORCID：0000-0001-9097-9125

发表论文 435 篇 · 总被引 10582 次 · h-index 30

代表论文

• Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial (2026 · Nature Communications · 被引 1)
• Abstract CT016: Feasibility and efficacy of perioperative nivolumab with or without relatlimab for patients with potentially resectable hepatocellular carcinoma (2026 · Cancer Research · 被引 1)
• Safety and immunologic impact of neoadjuvant/adjuvant GVAX, cyclophosphamide, pembrolizumab, and anti-CSF1R agent IMC-CS4 in pancreatic adenocarcinoma (2026 · Frontiers in Immunology · 被引 1)
• Phase II study of NC410 and FOLFIRINOX in combination with nivolumab with or without ipilimumab in patients with treatment-naive metastatic pancreatic cancer. (2026 · Journal of Clinical Oncology)
• Abstract 5620: Development of T cell receptor (TCR) based cellular therapy for fibrolamellar HCC uncovers role of TCR in CD4 T cell differentiation (2026 · Cancer Research)
• The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II study (2026 · Nature Communications)